Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15591978 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL2403123 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL715461 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL711967 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL13748874 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL15591996 | 1.00 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL13748877 | 0.97 | CHRM2 (0.48) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL817873 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL15591989 | 0.97 | CHRM2 (0.48) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL560600 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020163704-A1 | POLYVALENT DERIVATIVES OF EMOXYPINE | ALSATECH, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| EP-2539389-B1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA INC (US) | 2017-12-20 | — | — | EP | disclosed |
| EP-2539389-B1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA INC (US) | 2017-12-20 | — | — | EP | disclosed |
| US-20170258825-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. | 2017-09-14 | — | — | US | disclosed |
| US-20170258825-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. | 2017-09-14 | — | — | US | disclosed |
| US-20170258825-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. | 2017-09-14 | — | — | US | disclosed |
| US-9655920-B2 | Amine polymers for use as bile acid sequestrants | RELYPSA, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9655920-B2 | Amine polymers for use as bile acid sequestrants | RELYPSA, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9655920-B2 | Amine polymers for use as bile acid sequestrants | RELYPSA, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20150239824-A1 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | UNIVERSITE DE STRASBOURG (FR) | 2015-08-27 | — | — | US | disclosed |
| US-20150239824-A1 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | UNIVERSITE DE STRASBOURG (FR) | 2015-08-27 | — | — | US | disclosed |
| EP-2888223-A2 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | Université de Strasbourg (FR) | 2015-07-01 | — | — | EP | disclosed |
| US-20140356316-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2014-12-04 | — | — | US | disclosed |
| US-20140356316-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2014-12-04 | — | — | US | disclosed |
| US-20140356316-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2014-12-04 | — | — | US | disclosed |
| WO-2014029888-A2 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | UNIVERSITE DE STRASBOURG (FR) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014029888-A2 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | UNIVERSITE DE STRASBOURG (FR) | 2014-02-27 | — | — | WO | disclosed |
| EP-2539389-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | Relypsa, Inc. (US) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011106548-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106548-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258825-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | NR1H4, SLC10A2, SLC10A1 | CHRM2 2634/4885DNM1 3666/4885CA12 3730/4885 |
| US-20150239824-A1 | BRANCHED OR MACROCYCLIC POLYAMINES AND USES THEREOF | SRM, SMS, PNMT | CHRM2 3949/4885DNM1 512/4885CA12 4212/4885 |
| US-20140356316-A1 | AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS | NR1H4, SLC10A2, SLC10A1 | CHRM2 2634/4885DNM1 3666/4885CA12 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.